Erik Terjesen, Managing Director, Silicon Foundry, a Kearney Company
Drug shortages have surged to their highest levels in decades. In early 2024, U.S. pharmacies reported more than 323 active shortages, spanning essential generics, injectables, and…
Continue Reading
What You Should Know:
– Horizon Health Network, operating across New Brunswick, Canada, has partnered with global health tech leader Qure.ai to implement a comprehensive AI suite for lung cancer care.
– The strategic collaboration is…
Continue Reading
What You Should Know:
– Tampa General Hospital (TGH) Cancer Institute has partnered with Reimagine Care to integrate an AI-enabled virtual cancer care program into its clinical pathways.
– The collaboration, backed by an investment from…
Continue Reading
Thyme Care, CenterWell partner to provide cancer care support in seven states | MobiHealthNews
Skip to main content…
Continue Reading
The efficacy of immunotherapy in bladder cancer (BCa) is highly influenced by tumor heterogeneity, underscoring the urgent need for mechanistic insights and precise molecular subtyping. Adenosine-to-inosine RNA editing (AIRE), a critical post-transcriptional mechanism driving…
Continue Reading
Background: Adverse events (AEs) related to cancer treatment represent a valuable source of information that can be used to adjust therapy for individual patients. The NIH developed the Common Terminology Criteria for Adverse Events…
Continue Reading
Using AI outreach to raise bowel cancer screening in rural Queensland | MobiHealthNews
Skip to main content…
Continue Reading
Australia unveils national cancer data framework and more briefs | Healthcare IT News
Skip to main content…
Continue Reading
What You Should Know:
– GE HealthCare and Mayo Clinic today announced the GE HealthCare-Mayo Clinic Initiative in Radiation Therapy, known as GEMINI-RT, an ambitious new collaboration that aims to transform personalized radiation therapy and cancer care.
– Building…
Continue Reading
Several life-threatening diseases have a major genetic component but gene testing for these conditions remains out of reach for many patients because current clinical guidelines don’t recommend the test. Why not?
By John Halamka, M.D.,…
Continue Reading
